VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
46 hedge funds and large institutions have $91.2M invested in VIVEVE MED INC in 2017 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 6 closing their positions.
417% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 6
119% more funds holding
Funds holding: 21 → 46 (+25)
23% more capital invested
Capital invested by funds: $74.3M → $91.2M (+$16.9M)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.99M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$3.21M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.93M |
| 4 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$1.68M |
| 5 |
AFS
Amtrust Financial Services
New York
|
+$1.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$3.73M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$3.21M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$2.38M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.58M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$1.58M |
VIVE Hedge Fund Activity: Q2 2017 in Review
46 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q2 2017, worth a combined $91.2M — up 23% from $74.3M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new VIVE positions and 6 closed out — a net gain of 25 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $4.99M. The largest seller was Wexford Capital, cutting an estimated $3.73M.
- 46 institutional investors held VIVEVE MED INC (VIVE) as of Q2 2017, up from 21 in Q1 2017.
- Funds reported $91.2M of VIVEVE MED INC stock for Q2 2017, up 23% quarter-over-quarter.
- 31 funds opened new VIVEVE MED INC positions in Q2 2017 and 6 closed out, a net change of +25 holders.
- The largest VIVEVE MED INC buyer in Q2 2017 was BlackRock, an estimated $4.99M added.
- The largest VIVEVE MED INC seller in Q2 2017 was Wexford Capital, an estimated $3.73M sold.
Based on aggregated 13F filings for Q2 2017.